Compare SDOT & LITS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SDOT | LITS |
|---|---|---|
| Founded | 2014 | 2000 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1M | 25.7M |
| IPO Year | 2019 | N/A |
| Metric | SDOT | LITS |
|---|---|---|
| Price | $13.37 | $0.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 140.2K |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 490.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,929,137.00 | N/A |
| Revenue This Year | $12.76 | N/A |
| Revenue Next Year | $5.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.08 | N/A |
| 52 Week Low | $0.14 | $0.69 |
| 52 Week High | $106.00 | $3.03 |
| Indicator | SDOT | LITS |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 47.38 |
| Support Level | $12.11 | $0.93 |
| Resistance Level | $35.50 | $0.99 |
| Average True Range (ATR) | 3.70 | 0.05 |
| MACD | -1.01 | -0.01 |
| Stochastic Oscillator | 2.98 | 27.76 |
Sadot Group Inc consisted of one distinct operating unit engaged in the Agri-Foods industry. Its operating unit was intended to be a Agri-Foods company engaged in farming, commodity trading and shipping of food and feed (e.g., soybean meal, wheat and corn) via dry bulk cargo ships across the globe.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.